How many clinical trials are studying REGN7508?

5 recruiting trials in our tracked data involve REGN7508.

What conditions is REGN7508 being studied for?

In our tracked recruiting trials, REGN7508 is being studied in trials for Atrial Fibrillation (AF), Atrial fibrillation, Lung cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 1 Phase 3 4

Condition	Trials
Atrial Fibrillation (AF) · REGN7508 for Atrial Fibrillation (AF)	3
Atrial fibrillation · REGN7508 for Atrial fibrillation	3
Lung cancer	2
Cancer-Associated Thrombosis (CAT)	1
Venous Thromboembolism (VTE)	1

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
NCT07410117 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 81 locations
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 35 locations
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
NCT07493304 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations